Carbenoxolone and hypokalaemia.
D000368:Aged; D000464:Alginates / Q000009:adverse effects; D000536:Aluminum Hydroxide / Q000009:adverse effects; D000863:Antacids / Q000009:adverse effects; D001639:Bicarbonates / Q000009:adverse effects; D002229:Carbenoxolone / Q000009:adverse effects*; D004338:Drug Combinations / Q000009:adverse effects; D005260:Female; D006034:Glycyrrhetinic Acid / Q000031:analogs & derivatives*; D006801:Humans; D007008:Hypokalemia / Q000139:chemically induced*; D010437:Peptic Ulcer / Q000188:drug therapy; D017640:Silicates; D012824:Silicic Acid / Q000009:adverse effects
D000464:Alginates; D000863:Antacids; D001639:Bicarbonates; D004338:Drug Combinations; D017640:Silicates; D012824:Silicic Acid; D000536:Aluminum Hydroxide; C021080:pyrogastrone; D002229:Carbenoxolone; D006034:Glycyrrhetinic Acid